Literature DB >> 27955976

Latent Class Analysis: An example for reporting results.

James B Schreiber1.   

Abstract

OBJECTIVE: The purpose of this paper is to provide a brief non-mathematical introduction to Latent Class Analysis (LCA) and a demonstration for researchers new to the analysis technique in pharmacy and pharmacy administration. LCA is a mathematical technique for examining relationships among observed variables when there may be collections of unobserved categorical variables. Traditionally, LCA focused on polytomous observed variables, but recent work has extended the types of data that can be utilized. Included in this introduction are basic guidelines for the information that should be part of a manuscript submitted for review. For the analysis, LatentGold is used, but I also include basic R code for running LCA and LC Regressions with the poLCA package.
Copyright © 2016 Elsevier Inc. All rights reserved.

Keywords:  Latent Class Analysis; Reporting results

Mesh:

Year:  2016        PMID: 27955976     DOI: 10.1016/j.sapharm.2016.11.011

Source DB:  PubMed          Journal:  Res Social Adm Pharm        ISSN: 1551-7411


  38 in total

1.  Characteristics, Early Development and Outcome of Parent-Reported Regression in Autism Spectrum Disorder.

Authors:  Sofie Boterberg; Rudy Van Coster; Herbert Roeyers
Journal:  J Autism Dev Disord       Date:  2019-11

2.  Well-being and Long-term Physical Activity Participation in Midlife Adults: A Latent Class Analysis.

Authors:  Jerrald L Rector; Sharon L Christ; Elliot M Friedman
Journal:  Ann Behav Med       Date:  2019-01-01

3.  Latent class analysis of placental histopathology: a novel approach to classifying early and late preterm births.

Authors:  Alexander J Layden; Marnie Bertolet; W Tony Parks; James M Roberts; Jennifer J Adibi; Janet M Catov
Journal:  Am J Obstet Gynecol       Date:  2022-03-11       Impact factor: 10.693

4.  Different needs in patients with schizophrenia spectrum disorders who behave aggressively towards others depend on gender: a latent class analysis approach.

Authors:  Moritz Philipp Günther; Steffen Lau; Sabine Kling; Martina Sonnweber; Elmar Habermeyer; Johannes Kirchebner
Journal:  Ann Gen Psychiatry       Date:  2021-03-13       Impact factor: 3.455

5.  Longitudinal Patterns of Mexican and Puerto Rican Children's Asthma Controller Medication Adherence and Acute Healthcare Use.

Authors:  Kimberly J Arcoleo; Colleen McGovern; Karenjot Kaur; Jill S Halterman; Jennifer Mammen; Hugh Crean; Deepa Rastogi; Jonathan M Feldman
Journal:  Ann Am Thorac Soc       Date:  2019-06

6.  Aggression Profiles in the Spanish Child Population: Differences in Perfectionism, School Refusal and Affect.

Authors:  María Vicent; Cándido J Inglés; Ricardo Sanmartín; Carolina Gonzálvez; José Manuel García-Fernández
Journal:  Front Behav Neurosci       Date:  2018-01-30       Impact factor: 3.558

7.  A Step Towards a Better Understanding of Pain Phenotypes: Latent Class Analysis in Chronic Pain Patients Receiving Multimodal Inpatient Treatment.

Authors:  Alexander Obbarius; Felix Fischer; Gregor Liegl; Nina Obbarius; Jan van Bebber; Tobias Hofmann; Matthias Rose
Journal:  J Pain Res       Date:  2020-05-14       Impact factor: 3.133

8.  Predictors of tyrosine kinase inhibitor adherence trajectories in patients with newly diagnosed chronic myeloid leukemia.

Authors:  Samantha E Clark; Zachary A Marcum; Jerald P Radich; Aasthaa Bansal
Journal:  J Oncol Pharm Pract       Date:  2020-11-11       Impact factor: 1.809

9.  Perfectionism Classes and Aggression in Adolescents.

Authors:  Cecilia Ruiz-Esteban; Inmaculada Méndez; Aitana Fernández-Sogorb; José Daniel Álvarez Teruel
Journal:  Front Psychol       Date:  2021-06-01

10.  Factors Associated With the Recurrence, Persistence, and Clearance of Asymptomatic Bacterial Vaginosis Among Young African American Women: A Repeated-Measures Latent Class Analysis.

Authors:  Makella S Coudray; Diana M Sheehan; Tan Li; Robert L Cook; Jane Schwebke; Purnima Madhivanan
Journal:  Sex Transm Dis       Date:  2020-12       Impact factor: 3.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.